TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $79,000 | -63.9% | 163,800 | 0.0% | 0.00% | – |
| Q1 2019 | $219,000 | +18.4% | 163,800 | 0.0% | 0.00% | – |
| Q4 2018 | $185,000 | -59.1% | 163,800 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $452,000 | -22.7% | 163,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $585,000 | -13.5% | 163,800 | -25.6% | 0.00% | 0.0% |
| Q1 2018 | $676,000 | -55.7% | 220,200 | -9.1% | 0.00% | -50.0% |
| Q4 2017 | $1,526,000 | -7.9% | 242,200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,657,000 | -4.1% | 242,200 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $1,727,000 | -20.9% | 242,200 | +2.0% | 0.00% | -25.0% |
| Q1 2017 | $2,182,000 | +140.8% | 237,400 | +5.7% | 0.00% | +100.0% |
| Q4 2016 | $906,000 | +0.1% | 224,700 | -4.9% | 0.00% | +100.0% |
| Q3 2016 | $905,000 | -16.6% | 236,200 | -6.4% | 0.00% | -50.0% |
| Q2 2016 | $1,085,000 | -10.0% | 252,400 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $1,205,000 | -56.5% | 260,300 | -5.7% | 0.00% | -50.0% |
| Q4 2015 | $2,768,000 | +1997.0% | 276,000 | +1459.3% | 0.00% | – |
| Q3 2015 | $132,000 | -84.3% | 17,700 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $840,000 | +229.4% | 17,700 | +152.4% | 0.00% | – |
| Q1 2015 | $255,000 | 0.0% | 7,013 | 0.0% | 0.00% | – |
| Q4 2014 | $255,000 | – | 7,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |